Abvc Biopharma, Inc. financial data

Symbol
ABVC on Nasdaq
Location
44370 Old Warm Springs Blvd., Fremont, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 32.8 % -5.1%
Debt-to-equity 123 % -36%
Return On Equity -64.6 % +71.2%
Return On Assets -31.8 % +57%
Operating Margin -923 % +79.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.5M shares +89.5%
Common Stock, Shares, Outstanding 19.5M shares +62.1%
Entity Public Float 7.2M USD +38.5%
Common Stock, Value, Issued 19.5K USD +62.1%
Weighted Average Number of Shares Outstanding, Basic 17.4M shares +53.6%
Weighted Average Number of Shares Outstanding, Diluted 17.4M shares +53.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 510K USD +234%
Cost of Revenue 763 USD -99.7%
Research and Development Expense 132K USD -59.1%
Operating Income (Loss) -3.99M USD +37.2%
Nonoperating Income (Expense) -542K USD +66.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.54M USD +43.1%
Income Tax Expense (Benefit) 23.6K USD
Net Income (Loss) Attributable to Parent -4.23M USD +43.5%
Earnings Per Share, Basic 0 USD/shares +74.5%
Earnings Per Share, Diluted 0 USD/shares +74.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 388K USD +212%
Accounts Receivable, after Allowance for Credit Loss, Current 1.53K USD -0.07%
Inventory, Net 11.5K USD
Assets, Current 2.77M USD +20%
Deferred Income Tax Assets, Net 34.3K USD -96.6%
Property, Plant and Equipment, Net 8.22M USD +3.61%
Operating Lease, Right-of-Use Asset 459K USD -24.3%
Other Assets, Noncurrent 141K USD
Assets 16.2M USD +102%
Employee-related Liabilities, Current 161K USD -87.1%
Accrued Liabilities, Current 3.7M USD +27%
Contract with Customer, Liability, Current 81.1K USD +2.03%
Liabilities, Current 6.53M USD +4.57%
Contract with Customer, Liability, Noncurrent 296K USD
Operating Lease, Liability, Noncurrent 177K USD -22.6%
Liabilities 6.75M USD +3.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 484K USD +11%
Retained Earnings (Accumulated Deficit) -72M USD -2.39%
Stockholders' Equity Attributable to Parent 7.01M USD +293%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 9.49M USD +516%
Liabilities and Equity 16.2M USD +102%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -540K USD +43.5%
Net Cash Provided by (Used in) Financing Activities 429K USD -53.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 19.5M shares +62.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -104K USD -80.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.08M USD +44.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.23K USD -8.24%
Deferred Tax Assets, Valuation Allowance 6.76M USD +8.32%
Deferred Tax Assets, Gross 6.76M USD +8.32%
Operating Lease, Liability 459K USD -24.3%
Depreciation 31.2K USD +5.13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.18M USD +44.8%
Lessee, Operating Lease, Liability, to be Paid 473K USD -22.3%
Property, Plant and Equipment, Gross 11.6M USD +3.08%
Operating Lease, Liability, Current 282K USD -25.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 52.9K USD -7.05%
Lessee, Operating Lease, Liability, to be Paid, Year One 111K USD -68.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.01 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.5K USD +611%
Lessee, Operating Lease, Liability, to be Paid, Year Three 52.9K USD
Deferred Tax Assets, Operating Loss Carryforwards 6.05M USD
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 52.9K USD
Operating Lease, Payments 117K USD +18.9%
Additional Paid in Capital 86.4M USD -0.81%
Depreciation, Depletion and Amortization 27.4K USD +15.4%
Share-based Payment Arrangement, Expense 1.13M USD -51.9%
Interest Expense 1.44M USD +333%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%